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Fractal dimension analysis (FDA) is modern mathematical method widely used to describing of complex and chaotic shapes when
classic methods fail. The main aim of this study was evaluating the influence of photodynamic therapy (PDT) with cystein proteases
inhibitors (CPI) on the number and morphology of blood vessels inside tumor and on increase of effectiveness of combined
therapy in contrast to PDT and CPI used separately. Animals were divided into four groups: control, treated using only PDT,
treated using only CPI and treated using combined therapy, PDT and CPI. Results showed that time of animal survival and
depth of necrosis inside tumor were significantly higher in CPI+PDT group in contrast to other groups. The higher value of fractal
dimension (FD) was observed in control group, while the lowest value was found in the group which was treated by cystein protease
inhibitors. The differences between FD were observed in CPI group and PDT+CPI group in comparison to control group. Our
results revealed that fractal dimension analysis is a very useful tool in estimating differences between irregular shapes like blood
vessels in PDT treated tumors. Thus, the implementation of FDA algorithms could be useful method in evaluating the efficacy of
PDT.
1. Introduction
One of the important factors responsible for the tumor
growth is blood supply. Many studies revealed that the
anatomic and spatial structure of tumor blood vessels is
more chaotic than that of the normal tissues. One of the
classic ways of analyzing the blood vessels is direct count in
the light microscope. Immunohistochemical staining is very
useful against specific proteins within blood vessel wall, for
example vascular endothelial growth factor (VEGF), basic
fibroblast growth factor (bFGF), cluster of differentiation
such as CD34, and others [1, 2]. Many studies show that
PDT is responsible for overexpression of VEGF in vivo and
in vitro [3–5]. However, in the case of such complex and
chaotic shapes of tumor blood vessels classic methods of
evaluation may fail. Fractal dimension analysis may be very
helpful in these cases. Fractal is a shape which is described
by potentially simple mathematic formulas. If these formulas
are iterated into infinity they may create shapes which we are
able of magnifying without the end and each time we can
see infinity numbers of shape details—it is a self similarity
feature. Classic examples of fractals are Cantor’s set, Koch’s
snowflake, and Sierpinski triangle (see Figure 1).
Many natural shapes are very similar to fractals, for
example, coastline, trees, clouds, bronchial tree, and blood
vessels network. Any above-mentioned structures poses
main feature of fractal—self-similarity. Ideal tool to describe
a fractal is the fractal dimension (FD). Fractal dimension is a
shape index and particularly it can be defined as a measure of
irregularly shaped objects. Irregularity in shape and behavior
is shared by all of the biological, including anatomical,
systems. In Euclidian geometry a number of dimension is
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integer, for example, 0 is a number of dimension of a point,
one number characterizes line, two dimensions built a sur-
face, and finally three dimensions create a space. Fractal is a
mathematical form where the dimension value is in the range
between 0 up to 3 without 0, 1, 2, 3. Fractal is intermediate
form between point and three-dimensional object. The lower
the value of FD the more regular is the shape.
Photodynamic therapy (PDT) is very well known as
the method of treating both cancer and noncancer lesions.
It comprises two main agents: a light and a photosen-
sitizer. Photosensitizer under the influence of light may
induce many photochemical reactions in cells which lead
to apoptosis, necrosis and autophagy [6–8]. There are
many modifications of PDT which may increase its effi-
ciency, for instance, electroporation, microdermabrasion or
encapsulation into liposomes [9–12]. All above-mentioned
modifications increase accumulation of photosensitizer in
tissues. Other way to modify could be the combination of
PDT with cysteine protease inhibitors (CPI) [13]. Cysteine
proteases are the family of enzymes which are involved into
the process of dissemination of malignant tumors [14].
The main aim of this study was to evaluate the influence
of PDT with CPI on the number and morphology of blood
vessels and increase of effectiveness of combined therapy
in contrast to PDT and CPI used separately. In order
to check this assumption we used the fractal dimension
analysis. We applied immunohistochemistry because the
colorful antibody-antigen reactions improve visualization of
the blood vessels as compared to standard HE staining. We
also aimed at evaluating whether the PDT combined with
CPI may increase the depth of tumor necrosis and survival
time of animals.
2. Materials and Methods
2.1. Animals. One hundred and twenty female Wistar rats
(medium weight—200 g) in the age of 3 up to 3,5 months
were divided into four groups (30 rats in each group).
Experiments were approved by the Local Ethics Committee
in Wroclaw.
2.2. Tumor. Mammary solid adenocarcinoma (Adenocarci-
noma solidum mammae) was obtained from the Institute of
Oncology in Gliwice, Poland, and this was implanted as the
suspension under the skin in volume 1 cm3 of tumor cells in
0,9% NaCl. The site of that implantation was left abdominal
region.
2.3. Photosensitizer. Chlorin e6 (Frontier Scientific, Inc.,
USA) was obtained in the crystal form and this was dissolved
in 0,9% NaCl alkalized by 0,05 M NaOH. Photosensitizer
was applied into peritoneum in the dose 10 mg/kg of body
weight.
2.4. Cysteine Protease Inhibitors (CPI). CPI was a kind gift
from dr Y. Saleh of the Department of Biochemistry, Wroclaw
Medical University. CPI were extracted from homogenate of
human placenta. Inhibitor was purified by chromatographic
methods. Purified and sterilized inhibitor was dissolved in
0,9% NaCl and applied subcutaneously in 500 μg dose per
rat.
2.5. Immunohistochemistry. After excision the tumors were
fixed in 4% formalin, embedded in paraffin blocks, and,
using microtome cut in 5 μm thick slices, stained using
anti-VEGF antibody (Sigma, USA) and anti-bFGF antibody
(Sigma, USA). Visualization of these growth factors was
achieved using Vectastain ABC Kit (Vector Laboratories,
Burlingame, CA, USA) and following instructions received
from the supplier of the kit. In our study we used 1 : 50
concentration for VEGF and bFGF. The expression of VEGF
and bFGF was estimated in endothelial cells of blood vessels
by two independent pathologists.
2.6. Source of Light. Irradiation was performed using halogen
lamp, Penta Lamps (Teclas, Switzerland) using built-in band
filter at the wavelength 654 ± 20 nm and total energy dose
−150 J/cm2.
2.7. Treatment Protocols. Control group—first day: tumor
implantation; fifth day: measurement of tumor necrosis.
Group which was treated using PDT (PDT)—first day:
tumor implantation, second day: application of chlorin e6 in
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the dose of 10 mg/kg of body weight, third day: irradiation,
fifth day: measurement of tumor necrosis.
Group which was treated using CPI (CPI)—first day:
tumor implantation, second day: application of cystein
protease inhibitors in 500 μg dose per animal, and fifth day:
measurement of tumor necrosis.
Group which was treated using PDT and CPI together
(PDT+CPI)—first day: tumor implantation, second day:
application of cystein protease inhibitors in 500 μg dose per
animal, third day: application of chlorin e6 in the dose of
10 mg/kg of body weight, fourth day: irradiation, and fifth
day: measurement of tumor necrosis.
On the fifth day, each group was divided into two equal
subgroups. In the first subgroup animals were sacrificed
using the lethal dose of bioketan. During the autopsy the
samples from the tumor, lungs, liver, and kidneys were taken
to microscopic examination.
Animals from the second subgroup were kept in order to
estimate the time of survival. In case of death of any animal
the autopsy was performed using the same protocol as in the
first subgroup.
2.8. Measurement of Necrosis Depth. Microscopic slides were
stained using standard hematoxylin-eosin method and next
they were evaluated in light microscope (Olympus BX40) in
200x magnification. Depth of necrosis was measured using
an eye-piece graticule.
2.9. Evaluation of the Number of Blood Vessels. Number of
blood vessels was counted on the microscopic glass slides
stained using anti-bFGF and anti-VEGF antibodies. We
chose randomly slides with 10 tumors (from 10 animals)
from each group. We counted the number of blood vessels
in five fields of view at the magnification 400x and next we
calculated the average number from these five fields.
2.10. Statistical Analysis. Every statistical analysis was per-
formed using Statistica version 6.0 (StatSoft Inc.). Hypothe-
ses were verified on 0,05 significance level. Due to lack of
normal distribution we used nonparametric Kolmogorov-
Smirnov test.
2.11. Fractal Dimension Analysis (FDA). We used computer
program Fractalyse version 2.4 (http://www.fractalyse.org/).
Any graphic operation was performed in GIMP version 2.4.7.
Fractalyse software enables measuring fractal dimension
using box-counting method. Fractal dimension (DS) is






whereDS—fractal dimension, ε—length of box which creates
mesh covering surface with examining pattern, N(ε)—
minimal number of boxes which are required to cover
examining pattern.
Microscopic slides which were stained using anti-VEGF
or anti-bFGF antibodies were examined using 100x magni-

































Figure 2: Influence of various treatment methods on time of
survival (SD—standard deviation).
1280 × 1024 points resolution. Next, the micrographs were
converted into the binary white and black format. We applied



















It was necessary to use the Laplace filter because this filter
is able to generate very precise and thin outlines of blood
vessels [16]. After all these procedures the micrographs
of blood vessels were entered to Fractalyse program for
estimating the fractal dimension.
3. Results
3.1. Influence of Various Treatment Methods on Time of
Survival. Figure 2 shows the average time of survival in
each group. Average survival time in control group was 24
days. The longest survival time was observed in the group
which was treated by PDT and CPI together, that is, 53
days. The groups of animals which were treated using only
one method (PDT or CPI separately) were characterized by
similar survival time, that is, 43 days. The average survival
time in every group was statistically different in comparison
to control group.
Table 1 shows percentage of completely cured (complete
responses) animals in each group. The animals were consid-
ered as completely cured when the survival time was 65 days
or longer and no palpable tumor was found. The highest
percentage of cure rate was observed in PDT+CPI group,
that is, 33,33%. In the PDT group it reached 13,33%, in CPI
group that percentage was only 6,67%. In control group none
of animal survived 65 days or more.
4 Computational and Mathematical Methods in Medicine
Table 1: Percentage of complete responses in animals treated with
different methods and in the control group.
Control group PDT CPI CPI+PDT
Percentage of
complete responses































Figure 3: Influence of various treatment methods on necrosis depth
(SD—standard deviation).
3.2. Influence of Various Treatment Methods on Necrosis
Depth. Figure 3 shows the average depth of necrosis within
the tumor. The lowest value was observed in control group
(5 mm). Separate application of PDT and CPI caused
increase of necrosis depth (for PDT 9,20 mm and 9,80 mm
for CPI). These values were significantly different in compar-
ison to the control group. There was no statistical difference
between the groups in which PDT and CPI were applied
separately. The highest value (15,87 mm) of necrosis depth
was noted in the group which was treated by PDT and CPI
together.
3.3. Influence of Various Treatment Methods on the Value of
Vessels’ Fractal Dimension. Figure 4 shows value of FD of
blood vessels. The higher value was noted in control group,
that is, 1,135 while the lowest value was observed in the group
which was treated by cystein protease inhibitors (0,933). The
differences between FD in comparison to control group were
observed in CPI group and PDT+CPI group (0,982). The
fractal dimension in PDT group was 1,037.
Table 2 shows the average number of vessels versus fractal
dimension analysis. The lowest number of vessels was seen
in control group (10 for VEGF and 8 for bFGF). Higher
numbers of vessels were observed in the PDT group (17 for
VEGF and 15 for bFGF) and in group PDT+CPI (18 for





























Figure 4: Influence of various treatment methods on the value of
vessels’ fractal dimension (SD—standard deviation).
Table 2: The average number of blood vessels versus fractal
dimension analysis in groups of animals treated with different
methods and in the control group.
Average number of vessels
Control group PDT CPI PDT+CPI
VEGF 10 17 11 18
bFGF 8 15 8 12
Fractal dimension 1,135 1,037 0,933 0,982
4. Discussion
Our results revealed that photodynamic therapy combined
with cystein protease inhibitors causes increase of effective-
ness of treatment in comparison to other methods. Higher
effectiveness of PDT with CPI results in longer survival time
of animals and greater depth of necrosis in the tumors.
The attempts of combining the photodynamic therapy with
cystein protease inhibitors seem to be reasonable and the
positive synergistic effects were observed in our previous
experiments [13].
The whole mechanism of photodynamic therapy is
not clear. Next to destruction of cells due to phototoxic
reactions, PDT influences blood vessels. Blood vessels inside
the tumor are very important target on the way to tumor
destruction. Many studies revealed that the time between
application of photosensitizer and irradiation plays a key role
in that damage. In case of rat chondrosarcoma, significant
changes within vessels were achieved in the group which was
irradiated 5 and 30 minutes after intravenous application of
benzoporphyrin derivative. In a group which was irradiated
after 180 minutes pathological lesions within vessels were
less intensive [17]. Blood vessel network is characterized
by highly complex spatial arrangement. Euclidean geometry
because of its applicability to linear and regular forms,
should not be applied to biological objects that one of
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their most important feature is the irregularity in shape.
Vascular network may be roughly considered as fractal.
Most of the natural shapes are similar to fractals. Trees,
clouds and neuronal network are good examples. Fractal
dimension is a very useful parameter in describing such
shapes. Many studies revealed significant differences in value
of FD between normal and tumor tissue or low grade versus
high grade tumors. The example of such dependence is the
difference between vascular average FD of low-grade renal
carcinoma (Ds = 1, 55) and highgrade (Ds = 1, 45) [18].
In case of renal carcinoma characterized by higher intensity
of necrosis Ds = 1, 38 versus Ds = 1, 52 in tumors without
necrosis. In case of liver tumors an average value of FD is
1,62 in comparison to surrounding tissue in which Ds = 1, 47
[18]. The results showed above indicate that the tumor vessel
network is more chaotic than in surrounding tissue.
Our results showed that the highest value of FD was
found in control group, which may suggest that the network
of blood vessels is here more complex than in other groups.
Application of PDT, CPI, and both methods together leads
to decrease of fractal dimension. The lowest value of FD
was observed in PDT+CPI group, thus showing that the
combined therapy results in less chaotic arrangement of
the blood vessels. The comparison of FD with quantity of
blood vessels revealed that the shape of blood vessels was
changed into more regular but amount of vessels was similar.
The similar conclusions appeared after the comparison of
number of vessels in PDT and PDT+CPI group. In both
mentioned groups the number of vessels was increased and
accompanied by the reduction of FD value. The general
increase of blood vessel number in PDT+CPI group may
suggest intensification of angiogenesis. Angiogenesis may
be a result of the feedback as a response to destruction of
blood vessels during PDT and to the increase in secretion of
VEGF and bFGF [3–5]. The increase of vessel number next
to reduction of fractal dimension proves that diameter of
vessels decreases (the lower fractal dimension—near to 0—
the shape more similar to point which may be interpreted as
a reduction of diameter).
Fractal dimension analysis of blood vessels may be
a very efficient tool which enables comparison of shape
and distribution of vessels on the surface. FD is widely
used analysis of shapes in various visualization techniques
for instance X-rays photos, ultrasonography and computed
tomography [19–21]. Analysis of fractal dimension requires
procedures which enable separation of examined shape and
background. In case of microscopic slides stained using the
routine hematoxylin-eosin method the dynamics of colors is
poor which may make difficulties in automatic separation of
examined shapes. Computer systems require strong contrast
images (very useful is the staining against CD34 in case of
analysis of blood vessels) and special algorithms to search out
examined shapes are also needed [2].
5. Conclusions
Our results revealed that fractal dimension analysis is a
very useful tool in estimating differences between irregular
shapes like blood vessels in PDT-treated tumors. Thus, the
implementation of FDA algorithms could be useful method
in evaluating the efficacy of PDT of tumors.
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